Latest Bolus Stories
First-of-its-kind medication management solution for manual IV bolus injections expected to be available commercially in spring 2015 FRANKLIN LAKES, N.J., Jan.
Forgetting to turn a clock back this weekend can be a minor inconvenience for most people, but forgetting about the changeover from Daylight Savings Time can be very dangerous for some patients with diabetes.
Ushering in the age of personalized self-injections FRANKLIN, Ohio, Sept.
QuikCal(TM) Boluses provide critically needed, highly-absorbable calcium in a rapid-release bolus system. OLATHE, Kan.
BRIDGEWATER, N.J., July 25, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go(TM) Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification.
SAN MATEO, Calif., June 27, 2011 /PRNewswire/ -- Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that it has completed dosing the first patient in Part B of the ongoing Phase I study.
A new study shows there are no significant differences in how heart failure patients fare when they're given diuretic therapy in one dose or continuously.
BRIDGEWATER, N.J., March 1, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S.
- An imitative word; an onomatopoetic word.